title: Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
abstract: The objective of the study was to determine the effects and the molecular background of interleukin-1 receptor antagonist (IL-1Ra) and vIL-10 double gene transfer into human synovial fibroblasts from patients with rheumatoid arthritis (RA) using the SCID mouse model for cartilage erosion in RA. RA synovial fibroblasts were transduced with retro- or adenoviruses encoding IL-1Ra and/or viral IL-10 (vIL-10). SCID mice were engrafted subcutaneously with IL-1Ra and vIL-10 transduced human rheumatoid synovial fibroblasts and normal cartilage. In parallel, gene expression analysis before and after gene transfer using RNA arbitrarily primed PCR in combination with cDNA array was performed. vIL-10 and IL-1Ra double gene transfer resulted in inhibition of cartilage invasion and degradation by RA synovial fibroblasts when compared with control transduced and non-transduced implants. Expression of key genes that were altered after double gene transfer were related to the activin pathway. The results demonstrate not only that virus-based gene transfer using a combination of two joint-protective genes is a feasible approach to inhibit cartilage degradation by activated RA synovial fibroblasts, but also that the underlying molecular effects include modulation of the activin pathway.
authors.affiliation: Department of Internal Medicine I, University of Regensburg, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Neumann
authors.forename: M
authors.initials: M
authors.lastname: Judex
authors.forename: F
authors.initials: F
authors.lastname: Kullmann
authors.forename: J
authors.initials: J
authors.lastname: Grifka
authors.forename: P D
authors.initials: PD
authors.lastname: Robbins
authors.forename: T
authors.initials: T
authors.lastname: Pap
authors.forename: R E
authors.initials: RE
authors.lastname: Gay
authors.forename: C H
authors.initials: CH
authors.lastname: Evans
authors.forename: S
authors.initials: S
authors.lastname: Gay
authors.forename: J
authors.initials: J
authors.lastname: Schölmerich
authors.forename: U
authors.initials: U
authors.lastname: Müller-Ladner
mesh_terms: D000199:Actins / Q000378:metabolism*; D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D002358:Cartilage, Articular / Q000276:immunology* / Q000473:pathology / Q000637:transplantation; D005260:Female; D005347:Fibroblasts / Q000276:immunology / Q000473:pathology / Q000637:transplantation; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D016753:Interleukin-10 / Q000235:genetics*; D051379:Mice; D016513:Mice, SCID; D023421:Models, Animal; D016133:Polymerase Chain Reaction / Q000379:methods; D012190:Retroviridae / Q000235:genetics; D012795:Sialoglycoproteins / Q000235:genetics; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology / Q000637:transplantation; D014161:Transduction, Genetic / Q000379:methods; D019076:Transgenes
chemical_list: D000199:Actins; C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins; D016753:Interleukin-10